» Articles » PMID: 16731230

Impaired Natural Immunity, Cognitive Dysfunction, and Physical Symptoms in Patients with Chronic Fatigue Syndrome: Preliminary Evidence for a Subgroup?

Overview
Journal J Psychosom Res
Specialty Psychiatry
Date 2006 May 30
PMID 16731230
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The diagnostic criteria of chronic fatigue syndrome (CFS) define a heterogeneous population composed of several subgroups. Past efforts to identify subgroup markers have met with mixed success. This study was designed to examine natural killer cell activity (NKCA) as a potential subgroup marker by comparing the clinical presentations of CFS patients with and without clinically reduced NKCA.

Methods: Forty-one female CFS patients were classified into having either low or normal NKCA levels. These subgroups were then compared on objective measures of cognitive functioning and subjective assessments of fatigue, vigor, cognitive impairment, and daytime dysfunction.

Results: Relative to CFS patients in the normal-NKCA subgroup, low-NKCA patients reported less vigor, more daytime dysfunction, and more cognitive impairment. In addition, low-NKCA patients performed less on objective measures of cognitive functioning relative to normal-NKCA patients.

Conclusions: The results are offered as preliminary evidence in support of using NKCA as an immunological subgroup marker in CFS. Findings are also discussed in terms of known associations between dysregulated immune functions, somatic symptoms, and psychological stress.

Citing Articles

Meta-analysis of natural killer cell cytotoxicity in myalgic encephalomyelitis/chronic fatigue syndrome.

Baraniuk J, Eaton-Fitch N, Marshall-Gradisnik S Front Immunol. 2024; 15:1440643.

PMID: 39483457 PMC: 11524851. DOI: 10.3389/fimmu.2024.1440643.


The Facilitation of Clinical and Therapeutic Discoveries in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Related Diseases: Protocol for the You + ME Registry Research Platform.

Ramiller A, Mudie K, Seibert E, Whittaker S JMIR Res Protoc. 2022; 11(8):e36798.

PMID: 35816681 PMC: 9369615. DOI: 10.2196/36798.


Systematic review and meta-analysis of cognitive impairment in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

Aoun Sebaiti M, Hainselin M, Gounden Y, Sirbu C, Sekulic S, Lorusso L Sci Rep. 2022; 12(1):2157.

PMID: 35140252 PMC: 8828740. DOI: 10.1038/s41598-021-04764-w.


A SWATH-MS analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction.

Sweetman E, Kleffmann T, Edgar C, de Lange M, Vallings R, Tate W J Transl Med. 2020; 18(1):365.

PMID: 32972442 PMC: 7512220. DOI: 10.1186/s12967-020-02533-3.


Elevated blood lactate in resting conditions correlate with post-exertional malaise severity in patients with Myalgic encephalomyelitis/Chronic fatigue syndrome.

Ghali A, Lacout C, Ghali M, Gury A, Beucher A, Lozach P Sci Rep. 2019; 9(1):18817.

PMID: 31827223 PMC: 6906377. DOI: 10.1038/s41598-019-55473-4.